
|
Research Funding Revenues
UHN Core Research Funding
(in thousands of dollars) |
|
Princess Margaret Hospital Foundation
|
15,341 |
|
Toronto General & Western Hospital Foundation |
2,502 |
Arthritis & Autoimmunity Research Centre Foundation |
1,259 |
|
Ministry of Health & Long Term Care |
2,850 |
|
Recoveries |
7,652 |
|
Investment income |
2,814 |
|
Other |
13,213 |
|
TOTAL |
45,631 |
|
|
UHN External Research Funding
(in thousands of dollars) |
|
|
Operating Grants |
74,719 |
|
Infrastructure / Maintenance Awards |
24,339 |
Clinical Studies |
17,997 |
|
Other |
9,759 |
|
Career / Traineeship Awards |
7,642 |
|
Corporate Contracts |
7,225 |
|
TOTAL |
141,681 |
|
|
| |
Major Sources of External Funding
(in thousands of dollars) |
|
|
Canadian Institutes of Health Research |
24,653 |
|
Canada Foundation for Innovation/OIT |
22,318 |
National Cancer Institute of Canada |
7,275 |
|
National Institutes of Health (US) |
6,843 |
|
Ontario Institute for Cancer Research |
4,581 |
|
Heart and Stroke Foundations |
3,973 |
| Ontario Genomics Institute |
2,726 |
| Canada Research Chairs Program |
2,556 |
|
All figures represent fiscal year 2006/07 and include Ontario Cancer Institute (Princess Margaret Hospital); Toronto General Research Institute (Toronto General Hospital); and Toronto Western Research Institute (Toronto Western Hospital).
These figures have been provided by UHN Research Financial Services and Research Grant and Contract Services. These figures have not been audited. However, they have been included in the overall UHN statements and, as a result, have been subjected to audit procedures deemed appropriate by auditors in order to determine their overall reasonableness. |
|
|
| |
External Agencies Funding UHN Research |
A-C |
|
|
|
Full Listing
|
Abbott Laboratories
Advanced Cardiovascular Systems
Advanced Neuromodulation Systems
Aegera Therapeutics
Agouron Pharma
Albert Einstein College of Medicine of Yeshiva University
Alberta Heritage Foundation for Medical Research
Alexion Pharmaceuticals
Allergan
American Association for Thoracic Surgery
American Association of Neurological Surgeons
American Cytoscope Makers
American Heart Association
American Society of Plastic Surgeons' Plastic Surgery Educational Foundation
American Society of Regional Anesthesia and Pain Medicine
Amgen
Amorfix Life Sciences
Amyotrophic Lateral Sclerosis Society of Canada
AOSpine North America
ArgiNOx Pharmaceuticals
Argonne National Laboratory
Argos Therapeutics
Arius Research
Arthritis Community Research & Evaluation Unit
Arthritis Society
Aspreva
Astellas Pharma Canada
Astra Pharma
AstraZeneca Canada
AtheroGenics
Atuka
Aventis Pasteur
Banting and Best Diabetes Centre
Bausch and Lomb
Baxter Healthcare
Baycrest
Bayer
Beckman Coulter
Bell Canada
BioAxone Therapeutic
BioChem Therapeutic
BioMimetic Therapeutics
Boehringer Ingelheim
Boston Scientific
Bristol-Myers Squibb
Burroughs Wellcome Fund
CAD Sciences
Calouste Gulbenkian Foundation
Canada Foundation for Innovation
Canada Research Chairs Program
Canadian Arthritis Network
Canadian Association of Gastroenterology
Canadian Breast Cancer Foundation
Canadian Breast Cancer Research Alliance
Canadian Breast Cancer Research Initiative
Canadian Coordinating Office for Health Technology Assessment
Canadian Cystic Fibrosis Foundation
Canadian Diabetes Association
Canadian Health Services Research Foundation
Canadian Institutes of Health Research
Canadian Liver Foundation
Canadian Neuromodulation Society
Canadian Patient Safety Institute
Canadian Urologic Oncology Group
Cancer Care Ontario
Cancer Research Institute
Cancer Research Society
Caprion Proteomics
Celgene
Cell Genesys
Centocor
Centre for Addiction and Mental Health
Centrum Foundation
CeraPedics
ChemBridge Research Laboratories
Chiron
Christopher Reeve Paralysis Foundation
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Craig H. Neilsen Foundation
CSL
CV Therapeutics
Cyanamid
Cyclacel Pharmaceuticals
|
|